Risk factors for Baerveldt glaucoma drainage implantation for uveitic glaucoma

Manako, Kiyofumi; Takahashi, Eri; Saruwatari, Junji; Matsumura, Tomoyo; Kojima, Sachi; Inoue, Toshihiro

doi:10.1038/s41598-023-29244-1

Cited by 5 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…9 . Other studies with small sample sizes reported the surgical results of BGI separately for each type of glaucoma [10][11][12][13][14][15] . The present study is unique because it examined 204 eyes of Japanese patients with different types of glaucoma and evaluated the long-term surgical outcome of BGI (350-mm 2 endplate) surgery.…”

Section: Discussionmentioning

confidence: 99%

Long-term outcomes of Baerveldt glaucoma implant surgery in Japanese patients

Iwasaki,

Komori,

Arimura

et al. 2023

Sci Rep

View full text Add to dashboard Cite

This study evaluated the long-term surgical outcomes of Baerveldt glaucoma implant (BGI) surgery in patients with refractory glaucoma (204 eyes/204 patients). Surgical failure was defined by: < 20% reduction in preoperative intraocular pressure (IOP), or criterion A (IOP > 21 mmHg), criterion B (IOP > 17 mmHg), or criterion C (IOP > 14 mmHg). Reoperation, loss of light perception vision, or hypotony also denoted failure. The probability of success at 5 years postoperatively using criteria A, B, and C was 72.4%, 49.7%, and 24.4%, respectively. The mean IOP decreased significantly from 32.7 ± 9.7 mmHg preoperatively to 13.1 ± 3.9 mmHg at 5 years; the mean number of glaucoma medications also decreased from 3.7 ± 1.2 to 1.8 ± 1.9 (both P < 0.01). The number of previous intraocular surgeries was significantly associated with failure in the multivariable analysis for criterion B (hazard ratio 1.30; P < 0.01) and criterion C (hazard ratio 1.19; P = 0.031). Early and late postoperative complications occurred in 82 (40.2%) and 28 (13.7%) eyes, respectively. Postoperative interventions were performed in 44 eyes (21.6%). BGI surgery resulted in significant long-term decreases in IOP and the number of glaucoma medications. BGI surgery is effective for refractory glaucoma. However, postoperative interventions due to complications are required in numerous cases.

show abstract

Section: Discussionmentioning

confidence: 99%

Long-term outcomes of Baerveldt glaucoma implant surgery in Japanese patients

Iwasaki,

Komori,

Arimura

et al. 2023

Sci Rep

View full text Add to dashboard Cite

show abstract

“…Manako et al have recently reported significant IOP reductions from around 30 mmHg to 15 mmHg 1 year postoperation following BGI surgery in UG patients. This corresponded to a 1-year success rate of 88% [ 112 ]. The authors reported that the use of immunosuppressive treatment (that indicated a strong inflammatory response) was a risk factor for failure.…”

Section: Tube Shunt Surgery In Uveitic Glaucomamentioning

confidence: 99%

Update on Diagnosis and Treatment of Uveitic Glaucoma

Halkiadakis,

Konstantopoulou,

Tzimis

et al. 2024

JCM

View full text Add to dashboard Cite

Glaucoma is a common and potentially blinding complication of uveitis. Many mechanisms are involved alone or in combination in the pathogenesis of uveitic glaucoma (UG). In terms of diagnostic evaluation, the effects of inflammatory activity in the retinal nerve fiber layer may be a source of bias in the interpretation of optical coherence tomography measurements. For the successful treatment of UG, the control of intraocular inflammation specific to the cause or anti-inflammatory treatment, combined with IOP management, is mandatory. The early institution of specific treatment improves the prognosis of UG associated with CMV. The young age of UG patients along with increased failure rates of glaucoma surgery in this group of patients warrants a stepwise approach. Conservative and conjunctival sparing surgical approaches should be adopted. Minimally invasive surgical approaches were proved to be effective and are increasingly being used in the management of UG along with the traditionally used techniques of trabeculectomy or tubes. This review aims to summarize the progress that recently occurred in the diagnosis and treatment of UG.

show abstract

Glaukom-Drainage-Implantate: Indikationen, OP-Management und Nachsorge

Mercieca,

Weber

2024

Augenheilkunde up2date

View full text Add to dashboard Cite

Glaukom-Drainage-Implantate (GDI) setzt man bei Patienten mit Sekundärglaukom ein, z. B. bei uveitischem oder neovaskulärem Glaukom, die unter lokaler Therapie unkontrolliert sind. Ebenso bei Fällen von Bindehautvernarbung, etwa nach vorausgegangener Vitrektomie oder erfolgloser Glaukomoperation (z. B. Trabekulektomie). Außerdem sind sie eine Therapieoption für kongenitale Glaukome, Aphakieglaukome oder bei iridokorneoendothelialen Syndromen.

show abstract

Risk factors for Baerveldt glaucoma drainage implantation for uveitic glaucoma

Cited by 5 publications

References 22 publications

Long-term outcomes of Baerveldt glaucoma implant surgery in Japanese patients

Long-term outcomes of Baerveldt glaucoma implant surgery in Japanese patients

Update on Diagnosis and Treatment of Uveitic Glaucoma

Glaukom-Drainage-Implantate: Indikationen, OP-Management und Nachsorge

Contact Info

Product

Resources

About